Stakeholders Gather To Discuss Pandemic Response And Next Steps
As Europe’s health emergency body HERA approaches its first anniversary, an unprecedented range of stakeholders including industry bodies will be meeting in December to discuss HERA’s achievements, while a separate event will showcase the next generation of vaccines for COVID-19 and other infections.
You may also be interested in...
Coronavirus Notebook: EMA OKs Moderna’s Second Bivalent Spikevax, New Deal Agreed To Boost Vaccine R&D And Manufacturing
The EU regulator has recommended extending the use of the mRNA COVID-19 vaccines to younger children, and EU ministers have formally endorsed two regulations intended to strengthen the response to the pandemic and future health emergencies, including through the joint procurement of vaccines.
The new committee, which will initially be in place for a year, will advise the French drug regulator when it is preparing its opinions on substitution in specific biosimilar product groups.
The TGA has taken a series of actions to address supply chain issues, including on the regulatory front, but it says more remains to be done and is asking stakeholders for suggestions in a new online survey.